Biol Reprod Lalor Postdoctoral Fellowships -- Application Deadline January 15, 2009
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


BOR - Papers in Press, published online ahead of print April 4, 2007.
Biol Reprod 2007, 10.1095/biolreprod.106.059618
This Article
Right arrow Full Text (Rapid PDF)
Right arrow All Versions of this Article:
77/2/209    most recent
biolreprod.106.059618v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bogan, R. L.
Right arrow Articles by Niswender, G. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bogan, R. L.
Right arrow Articles by Niswender, G. D.
Agricola
Right arrow Articles by Bogan, R. L.
Right arrow Articles by Niswender, G. D.
Submitted December 19, 2006
Returned for revision January 7, 2007
Accepted April 3, 2007

Mechanisms of Hormone Action


Constitutive Steroidogenesis in Ovine Large Luteal Cells May Be Mediated by Tonically Active Protein Kinase A

R. L. Bogan and G. D. Niswender *

* To whom correspondence should be addressed. E-mail: gordon.niswender{at}colostate.edu.

Abstract
The mechanisms responsible for the increased basal rates of progesterone secretion from large steroidogenic luteal cells compared to small steroidogenic luteal cells have not been clearly defined. To determine if protein kinase A (PKA) is tonically active in large cells, the adenylate cyclase activator forskolin and a specific PKA inhibitor (PKI) were utilized in a 2x2 factorial treatment with each steroidogenic cell type. Progesterone and cAMP production were quantified following treatments. In addition, the effect of treatments on concentrations and the relative phosphorylation state of steroidogenic acute regulatory (STAR) protein in the two cell types was determined as a marker for PKA activity. Treatment with PKI blocked forskolin-induced increases in progesterone secretion by small luteal cells without affecting cAMP production. Treating large cells with PKI significantly decreased basal progesterone secretion in the presence or absence of forskolin, indicating that the high level of steroidogenesis by this cell type required PKA activity. There were no differences in steady-state concentrations of STAR protein due to treatment in either cell type. However, the percentage of relative STAR phosphorylation was higher in large compared to small cells and PKI treatment significantly decreased the phosphorylation state of STAR in large cells. Relative phosphorylation state of STAR and concentrations of progesterone in media were significantly correlated over treatments in both cell types. The ratio of progesterone secreted per picogram of cAMP was higher in large than small cells, and this was accompanied by a significant increase in the ratio of relative STAR phosphorylation to steady-state concentrations of STAR protein. These data are compatible with the theory that large luteal cells are constitutively steroidogenic at least in part because they have tonically active PKA. In addition, phosphorylation of STAR appears to be a primary effect of PKA on the activity of STAR protein in both types of ovine steroidogenic luteal cells.

Key words: Mechanisms of Hormone Action • Corpus luteum • Kinases • Progesterone





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Copyright © 2007 by the Society for the Study of Reproduction.